Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 3/2015

01-06-2015 | Letter to the Editor

Large discrepancies in linezolid use between French teaching hospitals: A comment on “Antimicrobial stewardship and linezolid”

Authors: G. G. Aubin, D. Boutoille, S. Corvec, J. Caillon, A. Caillaud, F. Moal, D. Navas

Published in: International Journal of Clinical Pharmacy | Issue 3/2015

Login to get access

Excerpt

Dear Editor, …
Literature
1.
go back to reference Guillard P, de La Blanchardière A, Cattoir V, Fischer M-O, Verdon R, Saint-Lorant G. Antimicrobial stewardship and linezolid. Int J Clin Pharm. 2014;36:1059–68.CrossRefPubMed Guillard P, de La Blanchardière A, Cattoir V, Fischer M-O, Verdon R, Saint-Lorant G. Antimicrobial stewardship and linezolid. Int J Clin Pharm. 2014;36:1059–68.CrossRefPubMed
2.
go back to reference Wunderink RG, Niederman MS, Kollef MH, Shorr AF, Kunkel MJ, Baruch A, et al. Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a randomized, controlled study. Clin Infect Dis. 2012;54:621–9.CrossRefPubMed Wunderink RG, Niederman MS, Kollef MH, Shorr AF, Kunkel MJ, Baruch A, et al. Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a randomized, controlled study. Clin Infect Dis. 2012;54:621–9.CrossRefPubMed
3.
go back to reference Boselli E, Breilh D, Rimmelé T, Djabarouti S, Toutain J, Chassard D, et al. Pharmacokinetics and intrapulmonary concentrations of linezolid administered to critically ill patients with ventilator-associated pneumonia. Crit Care Med. 2005;33:1529–33.CrossRefPubMed Boselli E, Breilh D, Rimmelé T, Djabarouti S, Toutain J, Chassard D, et al. Pharmacokinetics and intrapulmonary concentrations of linezolid administered to critically ill patients with ventilator-associated pneumonia. Crit Care Med. 2005;33:1529–33.CrossRefPubMed
4.
go back to reference Aubin G, Lebland C, Corvec S, Thomaré P, Potel G, Caillon J, et al. Good practice in antibiotic use: what about linezolid in a French university hospital? Int J Clin Pharm. 2011;33:925–8.CrossRefPubMed Aubin G, Lebland C, Corvec S, Thomaré P, Potel G, Caillon J, et al. Good practice in antibiotic use: what about linezolid in a French university hospital? Int J Clin Pharm. 2011;33:925–8.CrossRefPubMed
5.
go back to reference Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, et al. Clinical practice guidelines by the infectious diseases society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. Clin Infect Dis. 2011;52:285–92.CrossRefPubMed Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, et al. Clinical practice guidelines by the infectious diseases society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. Clin Infect Dis. 2011;52:285–92.CrossRefPubMed
6.
go back to reference Van Hal SJ, Paterson DL, Lodise TP. Systematic review and meta-analysis of vancomycin-induced nephrotoxicity associated with dosing schedules that maintain troughs between 15 and 20 milligrams per liter. Antimicrob Agents Chemother. 2013;57:734–44.CrossRefPubMedCentralPubMed Van Hal SJ, Paterson DL, Lodise TP. Systematic review and meta-analysis of vancomycin-induced nephrotoxicity associated with dosing schedules that maintain troughs between 15 and 20 milligrams per liter. Antimicrob Agents Chemother. 2013;57:734–44.CrossRefPubMedCentralPubMed
Metadata
Title
Large discrepancies in linezolid use between French teaching hospitals: A comment on “Antimicrobial stewardship and linezolid”
Authors
G. G. Aubin
D. Boutoille
S. Corvec
J. Caillon
A. Caillaud
F. Moal
D. Navas
Publication date
01-06-2015
Publisher
Springer Netherlands
Published in
International Journal of Clinical Pharmacy / Issue 3/2015
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-015-0091-6

Other articles of this Issue 3/2015

International Journal of Clinical Pharmacy 3/2015 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.